EXPERT COMMENTARY ON THE PRODUCT PROFILE OF Margetuximab for HER2-Positive Breast Cancer.
Citation metadata
From:
Oncology(Vol. 35, Issue 9)
Publisher:
Intellisphere, LLC
Document Type:
Brief article
Length:
349 words
Lexile Measure:
1120L
Document controls
Main content
Source Citation
Gale Document Number: GALE|A679525839